治療床市場 - 2026-2031 年預測

預計治療床市場將從 2025 年的 53.61 億美元成長到 2031 年的 69.58 億美元，複合年成長率為 4.44%。

慢性病盛行率上升、人口老化以及人們對睡眠障礙的認知不斷提高，推動了治療床市場強勁成長。這些特殊病床旨在促進特定疾病或身體障礙患者的健康並改善其睡眠質量，並提供可調節功能以滿足不同患者的需求。治療床的許多好處，加上慢性病負擔加重、人口結構變化、人們對睡眠障礙的認知不斷提高以及對預防壓瘡的日益重視，共同推動了市場擴張。

主要市場促進因素

治療床的優勢

治療床為患有各種疾病的患者、老年人和需要特殊護理的人士提供許多益處。這些床的設計旨在提供最佳舒適度，讓患者能夠更好地休息和睡眠。其可調節性，包括高度調節和個人化定位，使患者能夠找到最適合自身需求的舒適支撐姿勢。治療床適用於多種疾病：呼吸系統疾病患者可受益於頭部抬高，而循環系統疾病患者則可受益於腿部抬高。這種多功能性使得治療床在各種臨床和居家照護環境中都發揮著重要作用。

慢性病盛行率

隨著糖尿病、心血管疾病和呼吸系統疾病等慢性病患者數量的增加，需要特殊醫療照護的患者群體日益壯大，推動了治療床市場的發展。癌症是全球首要死因，2020年約有1,000萬人死於癌症，約佔全球死亡總數的六分之一。全球約有4.22億人患有糖尿病，2000年至2019年間盛行率增加了3%。對於從醫院過渡到居家照護的慢性疾病患者，治療床能夠提供持續的護理，有效控制症狀，並提高患者在院外的生活品質。

人口結構方面的必然要求

老年人通常需要更專業的照顧和幫助，而治療床對於為他們提供舒適安全的睡眠環境至關重要。隨著世界人口老化，老年人醫療保健服務和產品的需求日益成長。預計到2050年，60歲及以上人口的比例將從2015年的12%上升至22%，這意味著老年人口將顯著成長。預期壽命也顯著提高，從2000年的66.8歲提高到2019年的73.3歲。這種人口結構變化導致對治療床的需求持續成長，因為壽命延長與慢性病患病率升高有關，從而增加了對專業睡眠環境和護理解決方案的需求。

對睡眠障礙的認知

人們對充足睡眠及其對整體健康影響的認知不斷提高，預計將推動治療床市場的擴張。各種項目和宣傳活動正在進行，以支持這一趨勢。美國國家睡眠基金會每年三月都會舉辦“全國睡眠意識週”，提醒人們睡眠與健康之間的重要連結。該基金會也出版《睡眠健康雜誌》，探討睡眠與健康的社會科學觀點。學術機構開設的課程旨在幫助學生全面且實用地了解睡眠障礙，涵蓋其潛在機制、臨床症狀和有效的管理策略。人們對睡眠在整體健康中所扮演角色的認知不斷提高，正在推動對優質睡眠解決方案的需求。

預防壓瘡

壓瘡（褥瘡）是行動不便患者面臨的一大難題。配備減壓功能的治療床和專用床墊對於預防這些疼痛且可能危及生命的壓瘡至關重要。在美國，每年約有250萬人罹患壓瘡。如此沉重的壓瘡負擔預計將推動治療床市場的成長。美國護理學會已實施圍手術全期瘡預防計劃，旨在透過積極的預防措施降低壓瘡的發生率。由於臨床療效和成本方面的考量，醫療保健系統日益重視壓瘡預防，治療床的普及速度正在加快。

市場約束

儘管治療床市場呈現成長態勢，但也面臨諸多挑戰。與傳統病床相比，治療床高成本相對較高，這對小規模醫療機構而言構成了一大障礙。部分治療床，尤其是配備先進功能或電子控制系統的，需要更複雜的安裝和定期維護，從而增加醫療機構的成本和時間負擔。此外，某些患者有特殊需求，傳統設計無法完全滿足，而缺乏高級自訂功能可能會限制其在某些人群中的應用。

區域和近期趨勢

由於慢性病發病率上升、人口老化、技術進步、人們對睡眠障礙的認知不斷提高以及政府的支持，預計北美在預測期內將佔據顯著的市場佔有率。 2021年，美國疾病管制與預防中心（CDC）向美國睡眠醫學會授予了一項為期三年的津貼，用於推廣睡眠呼吸中止症的教育和宣傳。過去十年糖尿病盛行率的顯著成長（影響了美國約3,730萬人）也進一步推動了市場成長。

2023 年 2 月，史賽克公司推出了 SmartMedic 平台，旨在增強醫院現有的ICU病床能力，這反映了重症監護病床技術的持續創新。

治療床市場持續發展，受到人口趨勢、慢性病負擔以及人們對睡眠品質在健康結果中作用的認知不斷提高的推動。

本報告的主要優勢：

• 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
• 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
• 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
• 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
• 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

• 歷史資料（2021-2025 年）和預測資料（2026-2031 年）
• 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
• 競爭對手定位、策略和市場佔有率分析
• 按業務板塊和地區（國家）分類的收入成長和預測分析
• 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

• 市場概覽
• 市場定義
• 分析範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策和法規
• 策略建議

第4章 技術展望

第5章 按產品分類的治療床市場

• 介紹
• 臨床床
  • 普通床
  • 加護病房床位
  • 兒童床
  • 產床
  • 其他
• 普通床
• 配件

第6章 依應用分類的治療床市場

• 介紹
• 急診護理病床
• 重症加護病床
• 長期照護床位

第7章 按最終用戶分類的治療床市場

• 介紹
• 醫院和診所
• 生殖醫學中心
• 其他

第8章：各地區的治療床市場

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 企業合併、協議、商業合作
• 競爭對手儀錶板

第10章：公司簡介

• Hill Rom, Inc.（Baxter）
• Stryker Corporation
• Invacare Corporation
• Medline Industries
• Medical Depot Inc.
• GF Health Products, Inc.
• Arjo
• Amico Group of Companies
• Bakare Beds Ltd.

第11章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 分析方法
• 簡稱

The therapeutic bed Market, with a 4.44% CAGR, is forecasted to expand from USD 5.361 billion in 2025 to USD 6.958 billion in 2031.

The therapeutic bed market is experiencing robust growth driven by rising chronic disease prevalence, aging populations, and increasing awareness of sleep disorders. These specialized beds-designed to provide health benefits and improve sleep quality for individuals with specific medical conditions or physical challenges-offer adjustable features addressing diverse patient needs. Various therapeutic bed advantages, combined with growing chronic disease burden, demographic shifts, sleep disorder awareness, and emphasis on pressure ulcer prevention, are propelling market expansion.

Primary Market Drivers

Therapeutic Bed Benefits

Therapeutic beds offer a wide range of benefits for patients with various medical conditions, elderly individuals, and those requiring specialized care. These beds are designed to provide optimal comfort, allowing patients to rest and sleep more comfortably. Adjustable features-including height adjustments and customizable positioning-enable patients to find the most comfortable and supportive positions for their specific needs. Therapeutic beds cater to various medical conditions: patients with respiratory issues may benefit from elevating the head to improve breathing, while individuals with circulation problems may benefit from elevating the feet. This versatility makes therapeutic beds valuable across diverse clinical scenarios and home care settings.

Chronic Disease Prevalence

Rising chronic disease prevalence-including diabetes, cardiovascular diseases, and respiratory disorders-has led to larger numbers of patients with specific medical needs, propelling the therapeutic bed market. Roughly 10 million deaths, or approximately one in six deaths, were caused by cancer in 2020, making it the leading cause of death globally. Around 422 million people are living worldwide with diabetes, with prevalence rates increasing by 3% between 2000 and 2019. For patients with chronic conditions transitioning from hospitals to homecare settings, therapeutic beds provide continuity of care, enabling effective symptom management and improved quality of life outside institutional settings.

Demographic Imperatives

Older adults often require more specialized care and support, making therapeutic beds crucial in providing comfortable and safe environments for aging individuals. As global populations continue aging, there is higher demand for healthcare services and products catering to elderly populations. The percentage of people aged over 60 years globally is expected to rise from 12% in 2015 to 22% by 2050, indicating substantial increases in elderly populations. Life expectancy has seen significant increases, rising from 66.8 years in 2000 to 73.3 years in 2019. This demographic evolution creates sustained demand for therapeutic beds as longer lifespans often correlate with increased chronic condition prevalence requiring specialized sleeping and care solutions.

Sleep Disorder Awareness

Growing awareness of restful sleep's value and its effects on general health is expected to bolster the therapeutic bed market. Various programs and awareness initiatives support this trend. National Sleep Awareness Week is organized annually in March by the National Sleep Foundation to reemphasize the important connection between sleep and health. The National Sleep Foundation also publishes Sleep Health Journal to explore social science perspectives on sleep and health. Educational institutions offer courses providing thorough and practical understanding of sleep disorders, covering underlying mechanisms, clinical manifestations, and effective management strategies. This growing recognition of sleep's role in overall health outcomes drives demand for solutions supporting quality sleep.

Pressure Ulcer Prevention

Pressure ulcers (bedsores) represent significant concerns for immobile patients. Therapeutic beds with pressure-relieving features and specialized mattresses are critical in preventing development of these painful and potentially dangerous sores. Approximately 2.5 million U.S. people develop pressure injuries annually. This substantial pressure ulcer burden is expected to aid therapeutic bed market growth. The Perioperative Pressure Ulcer Program is being run by the American Academy of Nursing to reduce pressure ulcer incidence through aggressive prevention methods. As healthcare systems increasingly prioritize pressure ulcer prevention due to clinical outcomes and cost considerations, therapeutic bed adoption accelerates.

Market Constraints

Despite positive growth trajectories, the therapeutic bed market faces challenges. Therapeutic beds can be relatively expensive compared to traditional beds, with high costs representing significant barriers for smaller healthcare facilities. Some therapeutic beds, particularly those with advanced features and electronic controls, may require more complex setup and regular maintenance, leading to additional costs and time investments for healthcare facilities. Additionally, certain patients can have particular requirements not completely met by conventional designs, with absence of highly customizable features potentially hampering applicability for some individuals.

Regional Dynamics and Recent Developments

North America is expected to hold significant market share during the forecast period, supported by increasing chronic diseases, rising elderly populations, technological advancements, growing sleep disorder awareness, and government support. The CDC awarded a 3-year grant in 2021 to the American Academy of Sleep Medicine to expand sleep apnea education and awareness. Diabetes prevalence increased significantly in the past decade, affecting around 37.3 million U.S. population, further driving market growth.

In February 2023, Stryker launched the SmartMedic platform enhancing existing ICU bed capabilities at hospitals, demonstrating ongoing innovation in therapeutic bed technology focused on critical care applications.

The therapeutic bed market continues evolving, driven by demographic trends, chronic disease burden, and growing recognition of sleep quality's role in health outcomes.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Therapeutic Bed Market Segmentation

• By Product
• Clinical Beds
• Regular Beds
• ICU Beds
• Pediatric Beds
• Birthing Beds
• Others
• Household Beds
• Accessories
• By Application
• Acute Care Beds
• Critical Care Beds
• Long-term Beds
• By End-User
• Hospital & Clinics
• Reproductive Care Centers
• Others
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. THERAPEUTIC BED MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Clinical Beds
  • 5.2.1. Regular Beds
  • 5.2.2. ICU Beds
  • 5.2.3. Pediatric Beds
  • 5.2.4. Birthing Beds
  • 5.2.5. Others
• 5.3. Household Beds
• 5.4. Accessories

6. THERAPEUTIC BED MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Acute Care Beds
• 6.3. Critical Care Beds
• 6.4. Long-term Beds

7. THERAPEUTIC BED MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospital & Clinics
• 7.3. Reproductive Care Centers
• 7.4. Others

8. THERAPEUTIC BED MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Hill Rom, Inc. (Baxter)
• 10.2. Stryker Corporation
• 10.3. Invacare Corporation
• 10.4. Medline Industries
• 10.5. Medical Depot Inc.
• 10.6. GF Health Products, Inc.
• 10.7. Arjo
• 10.8. Amico Group of Companies
• 10.9. Bakare Beds Ltd.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations